$1.81
-0.05-2.69%
At close: -
$1.83
0.021.10%
After Hours: Jan 14, 7:45 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for XTL Biopharmaceuticals in recent months.
Browse guidance and forecast on all stocks.